Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: Optimizing a treatment protocol

Archives of Dermatology

Volumn 147, Issue 9, 2011, Pages 1116-1117

  DeKlotz, Cynthia M C ^a,b   Ogram, Alicia E ^a,b   Singh, Saurabh ^a,b   Dronavalli, Sridhar ^a,b   MacGregor, Jennifer L ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANOLIN ALCOHOL; PETROLATUM; RAPAMYCIN;

APPLICATION SITE BURNING; CASE REPORT; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; DRUG TOLERABILITY; FACIAL ANGIOFIBROMA; HEMANGIOFIBROMA; HUMAN; IRRITANT DERMATITIS; LETTER; OINTMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

ANGIOFIBROMA; FACIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SIROLIMUS; TUBEROUS SCLEROSIS;

EID: 80053078020     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.254     Document Type: Letter

References (2)

1. Haemel AK,O'Brian AL, Teng JM. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis. Arch Dermatol. 2010;146(7):715-718.
2. McNamara EK, Curtis AR, Fleischer AB. Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin [published online August 1, 2010]. J Dermatolog Treat. doi:10.3109/09546634.2010.489598.